Compass Therapeutics CMPX
NASDAQ CMPX
$0.84 +0.00 (+0.50%)
As of: Oct 21, 2026 · 10:50 AM EDT

Compass Therapeutics (CMPX) Long-Term Debt Issuances (2018 - 2019)

Updated

Compass Therapeutics' Long-Term Debt Issuances was $30,985 in FY2020.

Analysis

Compass Therapeutics (CMPX) Long-Term Debt Issuances (2018 - 2019) Analysis & Trends

  • Per Business Quant data, Long-Term Debt Issuances in earlier years was $20,985 in FY2019 and $34,525 in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,132.04 Bn 1,100.62 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 614.86 Bn 533.39 Bn 17.26 Bn -
3 AbbVie 503.32 Bn 476.44 Bn 12.70 Bn -
4 Merck 367.14 Bn 321.52 Bn 12.21 Bn -
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 261.69 Bn 235.37 Bn 12.86 Bn -
7 Amgen 236.43 Bn 191.82 Bn 7.24 Bn -
8 Gilead Sciences 190.71 Bn 164.90 Bn 6.22 Bn -
9 Pfizer 170.03 Bn 116.68 Bn 10.94 Bn -
10 Compass Therapeutics 156.59 Mn -649.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 -1,615.00
Mar 31, 2019 10,000.00
Dec 31, 2018 14,115.00
Jun 30, 2018 15,100.00
API Access

Compass Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=CMPX&period=max&api_key=YOUR_API_KEY